Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
3.1. Market Snippet by Drug
3.2. Market Snippet by Route of Administration
3.3. Market Snippet by Distribution Channel
3.4. Market Snippet by Region
4. Market Dynamics
4.1. Market Impacting Factors
4.2. Drivers
4.2.1. Rising R&D investments
4.2.2. The growing number of pipeline drugs
4.2.3. XX
4.3. Restraints:
4.3.1. Side-effects caused by drugs
4.3.2. XX
4.4. Opportunity
4.5. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Epidemiology
5.3. Pipeline Analysis
5.4. Supply Chain Analysis
5.5. Pricing Analysis
5.6. Regulatory Analysis
5.7. Unmet Needs
6. By Drug
6.1. Introduction
6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug
6.1.2. Market Attractiveness Index, By Drug Segment
6.2. Rituximab (Rituxan)*
6.2.1. Introduction
6.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
6.3. Cyclophosphamide (Cytoxan)
6.4. Azathioprine
6.5. Prednisone
6.6. Avacopan
6.7. Others
7. By Route of Administration
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration.
7.1.2. Market Attractiveness Index, By Route of Administration Segment
7.2. Oral*
7.2.1. Introduction
7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
7.3. Injectable
8. By Distribution Channel
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel Segment
8.1.2. Market Attractiveness Index, By Distribution Channel Segment
8.2. Hospital pharmacies*
8.2.1. Introduction
8.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
8.3. Retail pharmacies
8.4. Online pharmacies
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug
9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration.
9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. The U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug
9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration.
9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. The U.K.
9.3.6.3. France
9.3.6.4. Italy
9.3.6.5. Spain
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration.
9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration.
9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. Australia
9.5.6.5. Rest of Asia Pacific
9.6. The Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration.
9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Celltrion Inc.*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. ChemoCentryx Inc.
11.3. Teijin Pharma Ltd.
11.4. Sandoz International GmbH
11.5. Genentech, Inc.
11.6. InflaRx N.V.
11.7. Bristol-Myers Squibb Company
11.8. Amerigen Pharmaceuticals Limited
11.9. TTY Biopharm Company Ltd.
12. DataM Intelligence
12.1. Appendix
12.2. About Us and Services
12.3. Contact Us